Tags

Type your tag names separated by a space and hit enter

Preimplantation Genetic Screening and The Success Rate of In Vitro Fertilization: A Three-Years Study on Iranian Population.
Cell J. 2021 Jan; 22(4):467-475.CJ

Abstract

Objective

In vitro fertilization (IVF) is one of the most efficient approaches within the context of assisted reproductive technology (ART) to treat infertility. High pregnancy rates have become the major index of successful IVF in clinical studies. It is not clear yet which factors are certainly responsible for IVF success, as various outcomes were obtained in different IVF centers with different settings. In this study, we aimed to address controversies in the interpretation of promising results of IVF with respect to preimplantation genetic screening (PGS).

Materials and Methods

In this retrospective case series study, we built a dataset containing data from 213 IVF patient candidates for PGS (654 embryos) with blastomere biopsy at day 3 and trophectoderm biopsy in day 5, referred to Royan Institute, Tehran, Iran from 2015 to 2018. Next, the data were analyzed to find influential factors affecting success rate of ART cycles.

Results

Data analyses showed that regardless of PGS indications (ART failures, recurrent miscarriage, chromosomal abnormalities, etc.), the pregnancy rate is influenced by maternal and embryonic factors such as the age of mother as well as quantity and quality of transferred embryos. Furthermore, genotyping of embryos using array comparative genomic hybridization (aCGH) depicted the highest rate of chromosomal aberrations for chromosomes 1, 16 and 19 while the lowest frequency for chromosomes 11 and 17. Similarly, we detected 463 genetically abnormal embryos by aCGH, among which only 41.9% could be detected by classical fluorescent in situ hybridization (FISH) method.

Conclusion

This study not only highlighted the advantages of aCGH over the FISH method in detection of chromosomal abnormalities, but also emphasized the importance of genetic abnormality as an indication for determination of IVF success rate.

Authors+Show Affiliations

Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Departments of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Electronic Address:gourabi@royaninstitute.org. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32347040

Citation

Totonchi, Mehdi, et al. "Preimplantation Genetic Screening and the Success Rate of in Vitro Fertilization: a Three-Years Study On Iranian Population." Cell Journal, vol. 22, no. 4, 2021, pp. 467-475.
Totonchi M, Babaabasi B, Najafi H, et al. Preimplantation Genetic Screening and The Success Rate of In Vitro Fertilization: A Three-Years Study on Iranian Population. Cell J. 2021;22(4):467-475.
Totonchi, M., Babaabasi, B., Najafi, H., Rezazadeh Valojerdi, M., Eftekhari-Yazdi, P., Karimian, L., Almadani, N., Mohseni Meybodi, A., Kimiai, M., Mashayekhi, M., Madani, T., & Gourabi, H. (2021). Preimplantation Genetic Screening and The Success Rate of In Vitro Fertilization: A Three-Years Study on Iranian Population. Cell Journal, 22(4), 467-475. https://doi.org/10.22074/cellj.2021.6784
Totonchi M, et al. Preimplantation Genetic Screening and the Success Rate of in Vitro Fertilization: a Three-Years Study On Iranian Population. Cell J. 2021;22(4):467-475. PubMed PMID: 32347040.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preimplantation Genetic Screening and The Success Rate of In Vitro Fertilization: A Three-Years Study on Iranian Population. AU - Totonchi,Mehdi, AU - Babaabasi,Babak, AU - Najafi,Hadi, AU - Rezazadeh Valojerdi,Mojtaba, AU - Eftekhari-Yazdi,Poopak, AU - Karimian,Lila, AU - Almadani,Navid, AU - Mohseni Meybodi,Anahita, AU - Kimiai,Morteza, AU - Mashayekhi,Mehri, AU - Madani,Tahereh, AU - Gourabi,Hamid, Y1 - 2020/04/22/ PY - 2019/02/24/received PY - 2019/07/21/accepted PY - 2021/01/01/pmc-release PY - 2020/4/30/entrez PY - 2020/4/30/pubmed PY - 2020/4/30/medline KW - Array Comparative Genomic Hybridization KW - Assisted Reproductive Technology KW - In Vitro Fertilization KW - Preimplantation Genetic Screening SP - 467 EP - 475 JF - Cell journal JO - Cell J VL - 22 IS - 4 N2 - Objective: In vitro fertilization (IVF) is one of the most efficient approaches within the context of assisted reproductive technology (ART) to treat infertility. High pregnancy rates have become the major index of successful IVF in clinical studies. It is not clear yet which factors are certainly responsible for IVF success, as various outcomes were obtained in different IVF centers with different settings. In this study, we aimed to address controversies in the interpretation of promising results of IVF with respect to preimplantation genetic screening (PGS). Materials and Methods: In this retrospective case series study, we built a dataset containing data from 213 IVF patient candidates for PGS (654 embryos) with blastomere biopsy at day 3 and trophectoderm biopsy in day 5, referred to Royan Institute, Tehran, Iran from 2015 to 2018. Next, the data were analyzed to find influential factors affecting success rate of ART cycles. Results: Data analyses showed that regardless of PGS indications (ART failures, recurrent miscarriage, chromosomal abnormalities, etc.), the pregnancy rate is influenced by maternal and embryonic factors such as the age of mother as well as quantity and quality of transferred embryos. Furthermore, genotyping of embryos using array comparative genomic hybridization (aCGH) depicted the highest rate of chromosomal aberrations for chromosomes 1, 16 and 19 while the lowest frequency for chromosomes 11 and 17. Similarly, we detected 463 genetically abnormal embryos by aCGH, among which only 41.9% could be detected by classical fluorescent in situ hybridization (FISH) method. Conclusion: This study not only highlighted the advantages of aCGH over the FISH method in detection of chromosomal abnormalities, but also emphasized the importance of genetic abnormality as an indication for determination of IVF success rate. SN - 2228-5806 UR - https://www.unboundmedicine.com/medline/citation/32347040/Preimplantation_Genetic_Screening_and_The_Success_Rate_of_In_Vitro_Fertilization:_A_Three-Years_Study_on_Iranian_Population DB - PRIME DP - Unbound Medicine ER -